You are here: Industry Insights > COVID-19

News List

Americans Have High Trust in Health Care Providers: Poll drugs
August 12, 2021
Doctors, nurses, and pharmacists are highly trusted by most Americans, a new survey shows.
COVID-19 Vaccine Safe, Recommended for Pregnant Women, CDC Says drugs
August 12, 2021
Pregnant women should not hesitate to get COVID-19 vaccines, the U.S. Centers for Disease Control and Prevention said in updated guidance issued Wednesday. Previously, the country's leading health agency had only said that pregnant women were "eligible" .
Motorsport Market from Auto Parts & Equipment Industry to have Negative Growth post-COVID-19 Pandemic|Discover Company Insights in Technavio prnewswire
August 12, 2021
Do you know the motorsport market size is expected to reach a value of $ 0.99 bn during 2020-2024? The "motorsport market by Type (F1, NASCAR, and Others) and Geography (Europe, North America, APAC, South America, and MEA).
AzurRx expands trial of drug for Covid-19-linked GI infections to Ukraine pharmaceutical-technology
August 12, 2021
AzurRx BioPharma has expanded the ongoing Phase II RESERVOIR clinical trial of FW-1022 for the treatment of Covid-19-related gastrointestinal (GI) infections in Ukraine.
Global Travel Management Services Market Procurement Intelligence Report with COVID-19 Impact Analysis | SpendEdge prnewswire
August 12, 2021
The Travel Management Services market will register an incremental spend of about USD 534 Billion, growing at a CAGR of 6.16% during the five-year forecast period.
Antibody cocktail therapy may cover more patients firstwordpharma
August 12, 2021
The Japanese health ministry is working to widen the scope of patients with COVID-19 who can receive treatment using an antibody cocktail, reported NHK WORLD-JAPAN.
Age restrictions on AstraZeneca shot have ended reports of rare clots -UK scientists firstwordpharma
August 12, 2021
No new cases of rare and severe blood clots following vaccination with AstraZeneca's COVID-19 shot have been reported in the UK in recent weeks after a decision to restrict its use in people under the age of 40, scientists said Wednesday.
I-Mab Reports Positive Interim Analysis from Phase 2/3 Study of its GM-CSF Antibody Plonmarlimab (TJM2) to Treat Patients with Severe COVID-19 cphi-online
August 12, 2021
I-Mab today announced positive interim data from its U.S. phase 2/3 study (NCT04341116) of plonmarlimab (also known as TJM2 or TJ003234) for the treatment of cytokine release syndrome (CRS) in patients with severe COVID-19.
World-First COVID Vaccine Booster Randomized Clinical Trial in Transplant Patients Proves Third Shot Is Very Effective prnewswire
August 12, 2021
Scientists with the Ajmera Transplant Centre at UHN have conducted a first-in-the-world randomized placebo-controlled trial of third dose COVID-19 booster vaccine for transplant patients that shows substantially improved protection.
BioIQ Approaches Milestone of One Million COVID-19 Tests and Record Health Testing in the Home as Delta Variant Cases Climb prnewswire
August 12, 2021
BioIQ, an industry leading digital population health and testing platform company for top U.S. employers, health plans, and government agencies, is preparing to conduct its 1 millionth COVID-19 test.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page